Combination Chemotherapy in Treating Patients With Colorectal Cancer
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known if the effectiveness of irinotecan combined
with fluorouracil in treating colorectal cancer varies depending on the patient's racial
background.
PURPOSE: Phase III trial to study the effectiveness of irinotecan combined with fluorouracil
in treating patients from different racial backgrounds who have colorectal cancer that is
advanced, recurrent, metastatic or has not responded to treatment with fluorouracil.